Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
about
Radiotherapy for Colorectal Cancer: Current Standards and Future PerspectivesComparative Analysis of Efficacy, Toxicity, and Patient-Reported Outcomes in Rectal Cancer Patients Undergoing Preoperative 3D Conformal Radiotherapy or VMAT.Addition of platinum derivatives to neoadjuvant single-agent fluoropyrimidine chemoradiotherapy in patients with stage II/III rectal cancer: protocol for a systematic review and meta-analysis (PROSPERO CRD42017073064).[Role of neoadjuvant radiotherapy for rectal cancer : Is MRI-based selection a future model?].[The selective waiving of neoadjuvant (chemo)radiotherapy for rectal cancer lacks evidence].
P2860
Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Comparative Outcomes of Neoadj ...... III Low and Mid Rectal Cancer.
@en
type
label
Comparative Outcomes of Neoadj ...... III Low and Mid Rectal Cancer.
@en
prefLabel
Comparative Outcomes of Neoadj ...... III Low and Mid Rectal Cancer.
@en
P2093
P2860
P1476
Comparative Outcomes of Neoadj ...... /III Low and Mid Rectal Cancer
@en
P2093
Alexis Ulrich
Ignazio Tarantino
Markus K Diener
Markus W Büchler
Yakup Kulu
P2860
P2888
P304
P356
10.1245/S10434-015-4832-5
P577
2015-08-25T00:00:00Z
P6179
1029678812